Fri, June 1, 2018
Thu, May 31, 2018
Wed, May 30, 2018
Tue, May 29, 2018

Cory Kasimov Maintained (BMRN) at Buy with Increased Target to $133 on, May 31st, 2018

Cory Kasimov of JP Morgan, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $127 to $133 on, May 31st, 2018.

Cory has made no other calls on BMRN in the last 4 months.



There are 9 other peers that have a rating on BMRN. Out of the 9 peers that are also analyzing BMRN, 0 agree with Cory's Rating of Hold.



These are the ratings of the 9 analyists that currently disagree with Cory


  • Liana Moussatos of "Wedbush" Maintained at Buy with Increased Target to $115 on, Tuesday, May 29th, 2018
  • M. Auster of "Credit Suisse" Maintained at Buy with Increased Target to $120 on, Friday, May 25th, 2018
  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $105 on, Friday, May 25th, 2018
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $113 on, Monday, April 30th, 2018
  • Alethia Young of "Credit Suisse" Maintained at Buy with Increased Target to $116 on, Friday, March 2nd, 2018
  • Andrew Peters of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $124 on, Friday, February 23rd, 2018
  • Joseph Schwartz of "Leerink Swann" Maintained at Buy with Decreased Target to $132 on, Friday, February 23rd, 2018
  • M. Ian Somaiya of "BMO Capital" Maintained at Buy with Increased Target to $125 on, Friday, February 23rd, 2018
  • Stephen Willey of "Stifel" Maintained at Strong Buy with Decreased Target to $102 on, Friday, February 23rd, 2018